Frontlight ResearchEarly access
Trial site
University Hospital - London Health Sciences Centre
- 10running trials
- 1closed trial
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- ALS (motor neurone disease)3 trials
- Amyloidosis2 trials
- Fatty liver disease (MASLD/MASH)1 trial
- Multiple sclerosis1 trial
- Myasthenia gravis1 trial
- Myeloproliferative neoplasms1 trial
- Osteoarthritis1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 36 trials
- Phase 12 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Not yet recruiting3 trials
- Recruiting3 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Celgene2 trials
- Ionis Pharmaceuticals, Inc.2 trials
- McMaster University1 trial
- Regeneron Pharmaceuticals1 trial
- and 1 more
Running trials
Recruiting
Recruiting
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Enrolling by invitation
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- ALS (motor neurone disease)3 recruiting
- Amyloidosis1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Multiple sclerosis1 recruiting
- Osteoarthritis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026